MMR Vaccination in Adults: Dose and Schedule
Adults require a 0.5 mL dose of MMR vaccine administered subcutaneously or intramuscularly, with most adults born in 1957 or later needing 1-2 doses depending on their risk category. 1
Dosing Specifics
The standard adult dose is 0.5 mL administered as a single injection via subcutaneous or intramuscular route 1. This is the same volume used in pediatric populations—there is no separate "adult dose" formulation.
Number of Doses Required
One Dose Sufficient For:
- General adult population born in 1957 or later without specific risk factors 2
- Rubella immunity in women of childbearing age 2
Two Doses Required For:
Adults in high-risk categories need 2 doses separated by at least 28 days (minimum 4 weeks) 3:
- Healthcare personnel (regardless of birth year if lacking immunity documentation) 2
- Students in post-secondary educational institutions 3
- International travelers 3
- Persons in outbreak settings 4
- Previously vaccinated with killed measles vaccine (1963-1967) 4
Birth Year Considerations
Adults born before 1957 are generally considered immune and do not require vaccination 2, 3. However, healthcare personnel born before 1957 should be considered for vaccination with 2 doses if they lack laboratory evidence of immunity 2.
Special Populations
Healthcare Workers
Healthcare personnel require 2 doses of MMR at appropriate intervals (minimum 28 days apart) regardless of birth year if they lack documented immunity 2. This is critical because healthcare workers have been documented to contract measles even when born before 1957 5.
Women of Childbearing Age
Women without evidence of rubella immunity should receive 1 dose of MMR if not pregnant. Pregnancy must be avoided for 1 month following vaccination 1. If found to be pregnant, vaccination should occur immediately postpartum before hospital discharge 4, 2.
Post-Exposure Prophylaxis
For measles exposure, administer 1 dose within 72 hours of exposure 1. The second dose (if indicated) should be given at least 28 days later 6.
Administration Details
- Route: Subcutaneous or intramuscular 1
- Volume: 0.5 mL per dose 1
- Interval between doses: Minimum 28 days (4 weeks) when 2 doses needed 3, 6
- Reconstitution: Must use provided sterile diluent; administer immediately or store at 2-8°C for maximum 8 hours 1
Common Pitfalls to Avoid
- Do not assume birth before 1957 equals immunity in healthcare workers—they need documented immunity or vaccination 2
- Do not delay the second dose beyond 4 weeks when two doses are indicated for high-risk individuals 3
- Do not administer to pregnant women—screen for pregnancy and counsel about 1-month avoidance post-vaccination 1
- Do not use if reconstituted vaccine contains particulates or appears discolored 1
The evidence strongly supports that serious adverse events are rare in adults, though non-serious events like injection site reactions (157 per 100,000 doses), arthropathy (263 per 100,000 doses), and rash (113 per 100,000 doses) are relatively common 7. These should be discussed during pre-vaccination counseling but should not deter vaccination in eligible individuals.